Vanda Pharmaceuticals (VNDA) Reports Q1 EPS of $0.06
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.08 +1.60%
Revenue Growth %: +24.1%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +24.1%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.06. Revenue for the quarter came in at $62.5 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- Analysts eye Intuit investor day for signs estimates have troughed
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
